Total Payments
$295,845
2024 Payments
$773.37
Companies
28
Transactions
109
Medicare Patients
24,543
Medicare Billing
$7.2M
Payment Breakdown by Category
Research$289,247 (97.8%)
Food & Beverage$3,972 (1.3%)
Consulting$2,608 (0.9%)
Gifts$17.24 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $289,247 | 9 | 97.8% |
| Food and Beverage | $3,972 | 93 | 1.3% |
| Consulting Fee | $2,608 | 6 | 0.9% |
| Gift | $17.24 | 1 | 0.0% |
Payments by Type
Research
$289,247
9 transactions
General
$6,597
100 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Bausch Health US, LLC | $289,455 | 13 | $0 (2020) |
| Kala Pharmaceuticals, Inc. | $2,434 | 3 | $0 (2021) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $634.95 | 9 | $0 (2020) |
| ABBVIE INC. | $452.63 | 11 | $0 (2024) |
| Alcon Vision LLC | $434.47 | 11 | $0 (2024) |
| Valeant Pharmaceuticals North America LLC | $297.46 | 3 | $0 (2017) |
| Allergan, Inc. | $190.63 | 9 | $0 (2021) |
| Omeros Corporation | $178.86 | 6 | $0 (2021) |
| Regeneron Healthcare Solutions, Inc. | $178.41 | 2 | $0 (2023) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $169.64 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $773.37 | 16 | ABBVIE INC. ($300.74) |
| 2023 | $529.73 | 15 | Regeneron Healthcare Solutions, Inc. ($120.89) |
| 2022 | $185.97 | 5 | Bausch & Lomb Americas Inc. ($132.91) |
| 2021 | $2,722 | 12 | Kala Pharmaceuticals, Inc. ($2,434) |
| 2020 | $34,252 | 15 | Bausch Health US, LLC ($33,958) |
| 2019 | $98,307 | 18 | Bausch Health US, LLC ($97,603) |
| 2018 | $158,102 | 11 | Bausch Health US, LLC ($157,895) |
| 2017 | $971.44 | 17 | Valeant Pharmaceuticals North America LLC ($297.46) |
All Payment Transactions
109 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | BIOTISSUE HOLDINGS INC. | — | Food and Beverage | In-kind items and services | $23.38 | General |
| 12/03/2024 | Alcon Vision LLC | LenSx (Device) | Food and Beverage | In-kind items and services | $86.58 | General |
| Category: Ophthalmology | ||||||
| 10/16/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $31.15 | General |
| Category: EYE CARE | ||||||
| 08/22/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $18.22 | General |
| Category: EYE CARE | ||||||
| 08/14/2024 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $14.95 | General |
| 07/24/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $19.57 | General |
| Category: EYE CARE | ||||||
| 07/15/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $21.86 | General |
| Category: EYE CARE | ||||||
| 06/26/2024 | Alcon Vision LLC | Clareon (Device) | Food and Beverage | In-kind items and services | $16.98 | General |
| Category: Ophthalmology | ||||||
| 06/11/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $18.95 | General |
| Category: EYE CARE | ||||||
| 05/03/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $27.72 | General |
| Category: EYE CARE | ||||||
| 04/16/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $24.78 | General |
| Category: EYE CARE | ||||||
| 03/27/2024 | ABBVIE INC. | XEN GLAUCOMA TREATMENT SYSTEM (Device) | Food and Beverage | In-kind items and services | $104.20 | General |
| Category: EYE CARE | ||||||
| 03/14/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $34.29 | General |
| Category: EYE CARE | ||||||
| 02/17/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $159.43 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 01/24/2024 | Glaukos Corporation | iStent inject Trabecular Micro-Bypass System (Device) | Food and Beverage | Cash or cash equivalent | $25.93 | General |
| Category: Glaucoma | ||||||
| 01/19/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $145.38 | General |
| Category: Ophthalmology | ||||||
| 11/29/2023 | Rayner Intraocular Lenses Limited | Omidria (Drug), RayOne EMV, RayOne Spheric | Food and Beverage | Cash or cash equivalent | $33.43 | General |
| Category: Ophthalmology | ||||||
| 09/21/2023 | NEW WORLD MEDICAL,INC. | — | Food and Beverage | In-kind items and services | $13.09 | General |
| 08/22/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $18.06 | General |
| Category: INSOMNIA | ||||||
| 08/08/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $17.88 | General |
| Category: TEPEZZA | ||||||
| 07/20/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $21.87 | General |
| Category: INSOMNIA | ||||||
| 07/19/2023 | AbbVie Inc. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $27.13 | General |
| Category: EYE CARE | ||||||
| 07/18/2023 | Harrow Eye, LLC | IHEEZO (Drug) | Food and Beverage | In-kind items and services | $96.18 | General |
| Category: OPTOMETRY | ||||||
| 07/10/2023 | Glaukos Corporation | — | Food and Beverage | Cash or cash equivalent | $43.62 | General |
| 07/07/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $12.84 | General |
| Category: INSOMNIA | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A STUDY TO DOCUMENT THE SAFETY AND EFFECTIVENESS OF A NEW OPHTHALMIC VISCOSURGICAL DEVICE OVD WHEN COMPARED TO A CONTROL OVD | Bausch Health US, LLC | $157,730 | 3 |
| BAUSCH & LOMB OVD DISPERSIVE DVISC40 STUDY S877 | Bausch Health US, LLC | $97,603 | 3 |
| A STUDY TO DOCUMENT THE SAFETY AND EFFECTIVENESS OF A NEW COHESIVE OVD WHEN COMPARED TO A CONTROL OVD | Bausch Health US, LLC | $33,914 | 3 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 6,513 | 16,676 | $4.2M | $2.1M |
| 2022 | 24 | 6,171 | 13,614 | $3.5M | $1.7M |
| 2021 | 24 | 6,095 | 13,552 | $3.7M | $1.9M |
| 2020 | 27 | 5,764 | 12,385 | $2.9M | $1.5M |
Total Patients
24,543
Total Services
56,227
Medicare Billing
$7.2M
Procedure Codes
103
All Medicare Procedures & Services
103 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 135 | 1,523 | $1.9M | $1.0M | 54.5% |
| 66984 | Removal of cataract with insertion of prosthetic lens | Facility | 2023 | 301 | 533 | $441,406 | $214,227 | 48.5% |
| 67028 | Injection of drug into eye | Office | 2023 | 264 | 1,720 | $693,463 | $166,445 | 24.0% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 1,283 | 1,535 | $230,250 | $140,249 | 60.9% |
| 92134 | Imaging of retina | Office | 2023 | 955 | 2,610 | $151,380 | $85,039 | 56.2% |
| J7999 | Compounded drug, not otherwise classified | Office | 2023 | 155 | 1,156 | $115,600 | $80,822 | 69.9% |
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2023 | 11 | 2,765 | $149,040 | $80,334 | 53.9% |
| 66821 | Removal of recurring cataract in lens capsule using a laser | Facility | 2023 | 171 | 216 | $78,840 | $56,057 | 71.1% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 512 | 838 | $87,152 | $55,354 | 63.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 490 | 549 | $79,605 | $47,811 | 60.1% |
| 92250 | Photography of the retina | Office | 2023 | 510 | 860 | $75,680 | $25,576 | 33.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 254 | 332 | $33,200 | $24,182 | 72.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 175 | 175 | $33,075 | $19,206 | 58.1% |
| 92136 | Measurement of corneal curvature and depth of eye | Office | 2023 | 404 | 864 | $44,991 | $16,455 | 36.6% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 158 | 158 | $28,598 | $16,132 | 56.4% |
| 66982 | Complex removal of cataract with insertion of prosthetic lens | Facility | 2023 | 17 | 19 | $20,425 | $10,465 | 51.2% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 194 | 201 | $22,311 | $8,728 | 39.1% |
| 92133 | Imaging of optic nerve | Office | 2023 | 246 | 267 | $15,486 | $7,511 | 48.5% |
| 67840 | Removal of growth of eyelid | Office | 2023 | 17 | 18 | $6,156 | $3,750 | 60.9% |
| 92025 | Ct scan of cornea | Office | 2023 | 86 | 91 | $4,095 | $2,611 | 63.8% |
| 66984 | Removal of cataract with insertion of prosthetic lens | Office | 2023 | 78 | 143 | $6,240 | $1,278 | 20.5% |
| 92002 | New patient problem focused exam of visual system | Office | 2023 | 20 | 20 | $1,960 | $1,178 | 60.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 15 | 15 | $905.00 | $704.09 | 77.8% |
| 76514 | Ultrasound scan of cornea to determine thickness | Office | 2023 | 62 | 68 | $1,224 | $552.66 | 45.2% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 90 | 975 | $1.2M | $680,355 | 55.8% |
About Dr. Bruce Silverstein, MD
Dr. Bruce Silverstein, MD is a Ophthalmology healthcare provider based in Redding, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/14/2005. The National Provider Identifier (NPI) number assigned to this provider is 1255326476.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bruce Silverstein, MD has received a total of $295,845 in payments from pharmaceutical and medical device companies, with $773.37 received in 2024. These payments were reported across 109 transactions from 28 companies. The most common payment nature is "" ($289,247).
As a Medicare-enrolled provider, Silverstein has provided services to 24,543 Medicare beneficiaries, totaling 56,227 services with total Medicare billing of $7.2M. Data is available for 4 years (2020–2023), covering 103 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Location Redding, CA
- Active Since 09/14/2005
- Last Updated 10/25/2012
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1255326476
Products in Payments
- DVISC40 (Device) $97,603
- CVISC50 (Device) $8,629
- EYSUVIS (Drug) $2,434
- VYZULTA (Drug) $338.71
- Omidria (Drug) $290.38
- LenSx (Device) $226.70
- BESIVANCE (Drug) $197.80
- DURYSTA (Drug) $196.54
- XDEMVY (Drug) $159.43
- ACTHAR (Biological) $158.98
- Cequa (Drug) $145.38
- Actemra (Biological) $125.00
- Humira (Biological) $124.76
- EYLEA (Biological) $120.89
- OZURDEX (Drug) $115.04
- BTOD (Device) $111.64
- XEN GLAUCOMA TREATMENT SYSTEM (Device) $104.20
- LOTEMAX GEL (Drug) $99.66
- Centurion (Device) $97.64
- IHEEZO (Drug) $96.18
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Redding
Dr. Christopher Myers, M.d, M.D
Ophthalmology — Payments: $8,954
Ophthalmology $8,954
Dr. Sean Sumsion, M.d, M.D
Ophthalmology — Payments: $3,894
Ophthalmology $3,894
Michael Sumsion, Md, MD
Ophthalmology — Payments: $3,199
Ophthalmology $3,199
Bryan Crum, Md, MD
Ophthalmology — Payments: $1,736
Ophthalmology $1,736
Derek Brink, D.o, D.O
Ophthalmology — Payments: $1,627
Ophthalmology $1,627
Robert Trent, Md, MD
Ophthalmology — Payments: $858.37
Ophthalmology $858.37